GetTopicDetailResponse(id=3c74901169a, topicName=補(bǔ)體5a受體抑制劑, introduction=補(bǔ)體5a受體抑制劑, content=null, image=null, comments=1, allHits=653, url=https://h5.medsci.cn/topic?id=90116, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=97357, tagList=[TagDto(tagId=97357, tagName=補(bǔ)體5a受體抑制劑)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1812713, encodeId=216e1812e1337, content=<a href='/topic/show?id=3c74901169a' target=_blank style='color:#2F92EE;'>#補(bǔ)體5a受體抑制劑#</a>, objectTitle=ChemoCentryx的Avacopan補(bǔ)體5a受體抑制劑治療血管炎的III期試驗(yàn)達(dá)到了主要終點(diǎn), objectType=article, longId=183997, objectId=f31218399ec7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f31218399ec7, replyNumber=0, likeNumber=114, createdTime=2020-08-20, rootId=0, userName=仁心濟(jì)世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f31218399ec7, moduleTitle=ChemoCentryx的Avacopan補(bǔ)體5a受體抑制劑治療血管炎的III期試驗(yàn)達(dá)到了主要終點(diǎn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f31218399ec7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
